Le Lézard
Classified in: Ebola virus, Health
Subject: ACC

ZINZINO AB (PUBL): PRELIMINARY SALES REPORT JANUARY 2023


Zinzino group revenue increased with a total of 18%, compared with the previous year

GOTHENBURG, Sweden, Feb. 3, 2023 /PRNewswire/ -- The revenue in January for Zinzino's sales markets increased by 18% and amounted to SEK 120.0 (102.1) million. Faun Pharma's external sales increased by 32% and amounted to SEK 9.1 (6.9) million. Overall, the Group increased revenues by 18% to SEK 129.1 (109.0) million compared with the previous year.

Revenues were distributed as follows:

Regions, mSEK

23-Jan

22-Jan

Change

The Nordics

23,1

26,0

-11 %

Central Europe

28,5

18,4

55 %

East Europe

32,8

28,6

15 %

South & West Europe

15,9

12,1

31 %

The Baltics

7,4

6,5

14 %

North America

6,3

4,4

43 %

Asia-Pacific

4,6

5,7

-19 %

Africa

1,4

0,4

250 %

Zinzino

120,0

102,1

18 %

Faun Pharma

9,1

6,9

32 %

Zinzino Group

129,1

109,0

18 %

Countries in regions:

-The Nordics: Denmark, Faroe Island, Finland, Iceland, Norway, Sweden
-Central Europe: Austria, Germany, Switzerland
-East Europe: Czech Republic, Slovakia, Hungary, Poland, Romania
-South & West Europe: Cyprus, France, Greece, Italy, Luxembourg, Malta, Netherlands, Slovenia, Spain, United Kingdom, Belgium, Ireland
-The Baltics: Estonia, Latvia, Lithuania
-North America: Canada, USA
-Asia-Pacific: Australia, Hong Kong, India, Malaysia, Singapore, Taiwan, Thailand
-Africa: South Africa

For more information:
Dag Bergheim Pettersen CEO Zinzino +47 (0) 932 25 700, zinzino.com

Pictures for publication free of charge:
[email protected]

Certified Adviser: Erik Penser Bank Aktiebolag, +46 (0) 8 463 83 00, email: [email protected]

Zinzino AB (publ) is obliged to publish this information in compliance with current EU regulations governing market abuse. The information was provided by the above contact person for publication at 11:00 the 3rd of February 2023.

The following files are available for download:

https://mb.cision.com/Main/10976/3708591/1824916.pdf

2301 Pressrelease Salesreport EN


These press releases may also interest you

at 01:05
Today scientists from Colossal Biosciences, the world's first de-extinction company, and the University of Melbourne announce a major step forward in the effort to save Australia's endangered northern quoll (Dasyurus hallucatus) from the invasive...

at 01:00
Global Heart Hub, the international alliance of heart...

7 mai 2024
Kirin Holdings Company, Limited (Kirin Holdings)(TOKYO:2503) and National Institute of Infectious Diseases (NIID) are jointly conducting studies to investigate the protective efficacy of L. lactis strain Plasma [postbiotic] (LC-Plasma) immunization...

7 mai 2024
Since 2019, NSG BioLabs has been a leader in co-working lab spaces in Singapore, and has nurtured over 40 biotech companies, of which the startups have achieved nearly US$400 million funding in total alongside significant business milestonesNSG...

7 mai 2024
Today, The Kids Mental Health Foundation (KMHF) hosted a panel alongside the Mental Health Storytelling, which is housed at the USC Annenberg Inclusion Initiative, in New York City. The...

7 mai 2024
The Board of Juno Pharmaceuticals Corporation is excited to announce the appointment of Jean-Guy Goulet as Chief Executive Officer (CEO). An executive with over 35 years of experience in the pharmaceutical industry, overseeing activities in Canada...



News published on and distributed by: